Advertisement

Research Article Free access | 10.1172/JCI117045

Transforming growth factor-beta activation in irradiated murine mammary gland.

M H Barcellos-Hoff, R Derynck, M L Tsang, and J A Weatherbee

Lawrence Berkeley Laboratory, University of California, Berkeley 94720.

Find articles by Barcellos-Hoff, M. in: JCI | PubMed | Google Scholar

Lawrence Berkeley Laboratory, University of California, Berkeley 94720.

Find articles by Derynck, R. in: JCI | PubMed | Google Scholar

Lawrence Berkeley Laboratory, University of California, Berkeley 94720.

Find articles by Tsang, M. in: JCI | PubMed | Google Scholar

Lawrence Berkeley Laboratory, University of California, Berkeley 94720.

Find articles by Weatherbee, J. in: JCI | PubMed | Google Scholar

Published February 1, 1994 - More info

Published in Volume 93, Issue 2 on February 1, 1994
J Clin Invest. 1994;93(2):892–899. https://doi.org/10.1172/JCI117045.
© 1994 The American Society for Clinical Investigation
Published February 1, 1994 - Version history
View PDF
Abstract

The biological activity of TGF-beta, an important modulator of cell proliferation and extracellular matrix formation, is governed by dissociation of mature TGF-beta from an inactive, latent TGF-beta complex in a process that is critical to its role in vivo. So far, it has not been possible to monitor activation in vivo since conventional immunohistochemical detection does not accurately discriminate latent versus active TGF-beta, nor have events associated with activation been defined well enough to serve as in situ markers of this process. We describe here a modified immunodetection method using differential antibody staining that allows the specific detection of active versus latent TGF-beta. Under these conditions, we report that an antibody raised to latency-associated peptide detects latent TGF-beta, and we demonstrate that LC(1-30) antibodies specifically recognize active TGF-beta 1 in tumor xenografts overproducing active TGF-beta 1, without cross-reactivity in tumors expressing similar levels of latent TGF-beta 1. We previously reported that TGF-beta immunoreactivity increases in murine mammary gland after whole-body 60Co-gamma radiation exposure. Using differential antibody staining we now show that radiation exposure specifically generates active TGF-beta 1. While latent TGF-beta 1 was widely distributed in unirradiated tissue, active TGF-beta 1 distribution was restricted. Active TGF-beta 1 increased significantly within 1 h of irradiation concomitant with decreased latent TGF-beta immunoreactivity. This rapid shift in immunoreactivity provides the first evidence for activation of TGF-beta in situ. This reciprocal pattern of expression persisted for 3 d and was accompanied by decreased recovery of latent TGF-beta 1 from irradiated tissue. Radiation-induced activation of TGF-beta may have profound implications for understanding tissue effects caused by radiation therapy.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (February 1, 1994): No description
Advertisement
Advertisement